427 related articles for article (PubMed ID: 20372119)
1. Evaluating a bacterial hypothesis in IBS using a modification of Koch's postulates: part 1.
Pimentel M
Am J Gastroenterol; 2010 Apr; 105(4):718-21. PubMed ID: 20372119
[TBL] [Abstract][Full Text] [Related]
2. Questioning the bacterial overgrowth hypothesis of irritable bowel syndrome: an epidemiologic and evolutionary perspective.
Spiegel BM
Clin Gastroenterol Hepatol; 2011 Jun; 9(6):461-9; quiz e59. PubMed ID: 21397724
[TBL] [Abstract][Full Text] [Related]
3. Bacterial concepts in irritable bowel syndrome.
Lin HC; Pimentel M
Rev Gastroenterol Disord; 2005; 5 Suppl 3():S3-9. PubMed ID: 17713456
[TBL] [Abstract][Full Text] [Related]
4. Small intestinal bacterial overgrowth in patients with irritable bowel syndrome.
Posserud I; Stotzer PO; Björnsson ES; Abrahamsson H; Simrén M
Gut; 2007 Jun; 56(6):802-8. PubMed ID: 17148502
[TBL] [Abstract][Full Text] [Related]
5. The small intestinal bacterial overgrowth. Irritable bowel syndrome hypothesis: implications for treatment.
Vanner S
Gut; 2008 Sep; 57(9):1315-21. PubMed ID: 18250127
[No Abstract] [Full Text] [Related]
6. Prevalence of small intestinal bacterial overgrowth in children with irritable bowel syndrome: a case-control study.
Scarpellini E; Giorgio V; Gabrielli M; Lauritano EC; Pantanella A; Fundarò C; Gasbarrini A
J Pediatr; 2009 Sep; 155(3):416-20. PubMed ID: 19535093
[TBL] [Abstract][Full Text] [Related]
7. Small intestine bacterial overgrowth in patients with irritable bowel syndrome.
Carrara M; Desideri S; Azzurro M; Bulighin GM; Di Piramo D; Lomonaco L; Adamo S
Eur Rev Med Pharmacol Sci; 2008; 12(3):197-202. PubMed ID: 18700692
[TBL] [Abstract][Full Text] [Related]
8. [Clinical features of irritable bowel syndrome with small intestinal bacterial overgrowth and a preliminary study of effectiveness of Rifaximin].
Liu ZJ; Wei H; Duan LP; Zhu SW; Zhang L; Wang K
Zhonghua Yi Xue Za Zhi; 2016 Jun; 96(24):1896-902. PubMed ID: 27373356
[TBL] [Abstract][Full Text] [Related]
9. A proof-of-concept study showing antibiotics to be more effective in irritable bowel syndrome with than without small-intestinal bacterial overgrowth: a randomized, double-blind, placebo-controlled trial.
Ghoshal UC; Srivastava D; Misra A; Ghoshal U
Eur J Gastroenterol Hepatol; 2016 Mar; 28(3):281-9. PubMed ID: 26731696
[TBL] [Abstract][Full Text] [Related]
10. Antibiotics for irritable bowel syndrome: rationale and current evidence.
Sachdev AH; Pimentel M
Curr Gastroenterol Rep; 2012 Oct; 14(5):439-45. PubMed ID: 22945316
[TBL] [Abstract][Full Text] [Related]
11. Comparison of lactulose and glucose breath test for diagnosis of small intestinal bacterial overgrowth in patients with irritable bowel syndrome.
Rana SV; Sharma S; Kaur J; Sinha SK; Singh K
Digestion; 2012; 85(3):243-7. PubMed ID: 22472730
[TBL] [Abstract][Full Text] [Related]
12. Bacterial flora in irritable bowel syndrome: role in pathophysiology, implications for management.
Quigley EM
J Dig Dis; 2007 Feb; 8(1):2-7. PubMed ID: 17261128
[TBL] [Abstract][Full Text] [Related]
13. [Small intestinal bacterial overgrowth in patients with functional gastrointestinal diseases].
Madrid AM; Defilippi C C; Defilippi G C; Slimming A J; Quera P R
Rev Med Chil; 2007 Oct; 135(10):1245-52. PubMed ID: 18180830
[TBL] [Abstract][Full Text] [Related]
14. Restless legs syndrome is associated with irritable bowel syndrome and small intestinal bacterial overgrowth.
Weinstock LB; Walters AS
Sleep Med; 2011 Jun; 12(6):610-3. PubMed ID: 21570907
[TBL] [Abstract][Full Text] [Related]
15. The prevalence of small intestinal bacterial overgrowth in irritable bowel syndrome: IBS vs healthy controls (not historical definitions).
Pimentel M
Gut; 2008 Sep; 57(9):1334-5; author reply 1335. PubMed ID: 18719147
[No Abstract] [Full Text] [Related]
16. Small intestinal bacterial overgrowth: diagnosis and treatment.
Gasbarrini A; Lauritano EC; Gabrielli M; Scarpellini E; Lupascu A; Ojetti V; Gasbarrini G
Dig Dis; 2007; 25(3):237-40. PubMed ID: 17827947
[TBL] [Abstract][Full Text] [Related]
17. Breath testing and antibiotics for possible bacterial overgrowth in irritable bowel syndrome.
Ford AC
Expert Rev Anti Infect Ther; 2010 Aug; 8(8):855-7. PubMed ID: 20695737
[No Abstract] [Full Text] [Related]
18. A 51-year-old with irritable bowel syndrome: test or treat for bacterial overgrowth?
Quigley EM
Clin Gastroenterol Hepatol; 2007 Oct; 5(10):1140-3. PubMed ID: 17916541
[No Abstract] [Full Text] [Related]
19. A study of the methodological and clinical validity of the combined lactulose hydrogen breath test with scintigraphic oro-cecal transit test for diagnosing small intestinal bacterial overgrowth in IBS patients.
Zhao J; Zheng X; Chu H; Zhao J; Cong Y; Fried M; Fox M; Dai N
Neurogastroenterol Motil; 2014 Jun; 26(6):794-802. PubMed ID: 24641100
[TBL] [Abstract][Full Text] [Related]
20. Clinical predictors of small intestinal bacterial overgrowth by duodenal aspirate culture.
Choung RS; Ruff KC; Malhotra A; Herrick L; Locke GR; Harmsen WS; Zinsmeister AR; Talley NJ; Saito YA
Aliment Pharmacol Ther; 2011 May; 33(9):1059-67. PubMed ID: 21395630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
